Login Register Cart 0
Generic placeholder image

Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1573-4064
ISSN (Online): 1875-6638

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

2, 4, 5-Trideoxyhexopyranosides Derivatives of 4’-Demethylepipodophyllotoxin: De novo Synthesis and Anticancer Activity

Author(s): Yapeng Lu, Li Zhu, Rui Cai, Yu Li and Yu Zhao*

Volume 18, Issue 1, 2022

Published on: 19 November, 2020

Page: [130 - 139] Pages: 10

DOI: 10.2174/1573406416666201120102250

Price: $65

Abstract

Background: Podophyllotoxin is a natural lignan which possesses anticancer and antiviral activities. Etoposide and teniposide are semisynthetic glycoside derivatives of podophyllotoxin and are increasingly used in cancer medicine.

Objective: The present work aimed to design and synthesize a series of 2, 4, 5-trideoxyhexopyranosides derivatives of 4’-demethylepipodophyllotoxin as novel anticancer agents.

Methods: A divergent de novo synthesis of 2, 4, 5-trideoxyhexopyranosides derivatives of 4’- demethylepipodophyllotoxin has been established via palladium-catalyzed glycosylation. The abilities of synthesized glycosides to inhibit the growth of A549, HepG2, SH-SY5Y, KB/VCR and HeLa cancer cells were investigated by MTT assay. Flow cytometric analysis of cell cycle with propidium iodide DNA staining was employed to observe the effect of compound 5b on cancer cell cycle.

Results: Twelve D and L monosaccharide derivatives 5a-5l have been efficiently synthesized in three steps from various pyranone building blocks employing de novo glycosylation strategy. Dmonosaccharide 5b showed the highest cytotoxicity on five cancer cell lines with the IC50 values ranging from 0.9 to 6.7 μM. It caused HepG2 cycle arrest at G2/M phase in a concentrationdependent manner.

Conclusion: The present work leads to the development of novel 2, 4, 5-trideoxyhexopyranosides derivatives of 4’-demethylepipodophyllotoxin. The biological results suggest that the replacement of the glucosyl moiety of etoposide with 2, 4, 5-trideoxyhexopyranosyl is favorable to their cytotoxicity. D-monosaccharide 5b was observed to cause HepG2 cycle arrest at the G2/M phase in a concentration- dependent manner.

Keywords: 4'-demethylepipodophyllotoxin, De novo synthesis, anticancer agents, 2, 4, 5-trideoxyhexopyranosides, glycosylation, cell cycle arrest.

« Previous Next »
Graphical Abstract

[1]
Zhang, X.; Rakesh, K.P.; Shantharam, C.S.; Manukumar, H.M.; Asiri, A.M.; Marwani, H.M.; Qin, H.L. Podophyllotoxin derivatives as an excellent anticancer aspirant for future chemotherapy: A key current imminent needs. Bioorg. Med. Chem., 2018, 26(2), 340-355.
[http://dx.doi.org/10.1016/j.bmc.2017.11.026] [PMID: 29269253]
[2]
Zhao, Y.; Wang, C.; Wu, Z.; Fang, J.; Zhu, L. Synthesis and antitumor activity of novel aroylthiourea derivatives of podophyllotoxin. Invest. New Drugs, 2012, 30(1), 17-24.
[http://dx.doi.org/10.1007/s10637-010-9508-1] [PMID: 20697773]
[3]
Shankaraiah, N.; Kumar, N.P.; Amula, S.B.; Nekkanti, S.; Jeengar, M.K.; Naidu, V.G.M.; Reddy, T.S.; Kamal, A. One-pot synthesis of podophyllotoxin-thiourea congeners by employing NH2SO3H/NaI: Anticancer activity, DNA topoisomerase-II inhibition, and apoptosis inducing agents. Bioorg. Med. Chem. Lett., 2015, 25(19), 4239-4244.
[http://dx.doi.org/10.1016/j.bmcl.2015.07.100] [PMID: 26292628]
[4]
Hande, K.R. Etoposide: four decades of development of a topoisomerase II inhibitor. Eur. J. Cancer, 1998, 34(10), 1514-1521.
[http://dx.doi.org/10.1016/S0959-8049(98)00228-7] [PMID: 9893622]
[5]
Jin, Y.; Chen, S.W.; Tian, X. Synthesis and biological evaluation of new spin-labeled derivatives of podophyllotoxin. Bioorg. Med. Chem., 2006, 14(9), 3062-3068.
[http://dx.doi.org/10.1016/j.bmc.2005.12.025] [PMID: 16406792]
[6]
Zi, C.T.; Li, G.T.; Li, Y.; Zhou, J.; Ding, Z.T.; Jiang, Z.H.; Hu, J.M. Synthesis and Anticancer Activity of 4β-Triazole-podophyllotoxin Glycosides. Nat. Prod. Bioprospect., 2015, 5, 83-90.
[http://dx.doi.org/10.1007/s13659-015-0057-3] [PMID: 25869591]
[7]
Keller-Juslén, C.; Kuhn, M.; Stähelin, H.; von Wartburg, A. Synthesis and antimitotic activity of glycosidic lignan derivatives related to podophyllotoxin. J. Med. Chem., 1971, 14(10), 936-940.
[http://dx.doi.org/10.1021/jm00292a012] [PMID: 5165570]
[8]
Liu, H.; Liao, J.X.; Hu, Y.; Tu, Y.H.; Sun, J.S. A highly efficient approach to construct (epi)-Podophyllotoxin-4-O-glycosidic linkages as well as its application in concise syntheses of Etoposide and Teniposide. Org. Lett., 2016, 18(6), 1294-1297.
[http://dx.doi.org/10.1021/acs.orglett.6b00216] [PMID: 26916150]
[9]
Berkowitz, D.B.; Choi, S.; Bhuniya, D.; Shoemaker, R.K. Novel “reverse Kahne-type glycosylation”: access to O-, N-, and C-linked epipodophyllotoxin conjugates. Org. Lett., 2000, 2(8), 1149-1152.
[http://dx.doi.org/10.1021/ol005732a] [PMID: 10804576]
[10]
Bhat, B.A.; Reddy, P.B.; Agrawal, S.K.; Saxena, A.K.; Kumar, H.M.; Qazi, G.N. Studies on novel 4β-[(4-substituted)-1,2,3-triazol-1-yl] podophyllotoxins as potential anticancer agents. Eur. J. Med. Chem., 2008, 43(10), 2067-2072.
[http://dx.doi.org/10.1016/j.ejmech.2007.09.015] [PMID: 17988764]
[11]
Castro, M.A.; Miguel del Corral, J.M.; Gordaliza, M.; García, P.A.; Gómez-Zurita, M.A.; García-Grávalos, M.D.; de la Iglesia-Vicente, J.; Gajate, C.; An, F.; Mollinedo, F.; San Feliciano, A. Synthesis and biological evaluation of new selective cytotoxic cyclolignans derived from podophyllotoxin. J. Med. Chem., 2004, 47(5), 1214-1222.
[http://dx.doi.org/10.1021/jm030978h] [PMID: 14971901]
[12]
Wu, G.R.; Xu, B.; Yang, Y.Q.; Zhang, X.Y.; Fang, K.; Ma, T.; Wang, H.; Xue, N.N.; Chen, M.; Guo, W.B.; Jia, X.H.; Wang, P.L.; Lei, H.M. Synthesis and biological evaluation of podophyllotoxin derivatives as selective antitumor agents. Eur. J. Med. Chem., 2018, 155, 183-196.
[http://dx.doi.org/10.1016/j.ejmech.2018.05.052] [PMID: 29886322]
[13]
Reddy, V.G.; Bonam, S.R.; Reddy, T.S.; Akunuri, R.; Naidu, V.G.M.; Nayak, V.L.; Bhargava, S.K.; Kumar, H.M.S.; Srihari, P.; Kamal, A. 4β-amidotriazole linked podophyllotoxin congeners: DNA topoisomerase-IIα inhibition and potential anticancer agents for prostate cancer. Eur. J. Med. Chem., 2018, 144, 595-611.
[http://dx.doi.org/10.1016/j.ejmech.2017.12.050] [PMID: 29289884]
[14]
Sun, W.X.; Ji, Y.J.; Wan, Y.; Han, H.W.; Lin, H.Y.; Lu, G.H.; Qi, J.L.; Wang, X.M.; Yang, Y.H. Design and synthesis of piperazine acetate podophyllotoxin ester derivatives targeting tubulin depolymerization as new anticancer agents. Bioorg. Med. Chem. Lett., 2017, 27(17), 4066-4074.
[http://dx.doi.org/10.1016/j.bmcl.2017.07.047] [PMID: 28757065]
[15]
Zi, C.T.; Yang, D.; Dong, F.W.; Li, G.T.; Li, Y.; Ding, Z.T.; Zhou, J.; Jiang, Z.H.; Hu, J.M. Synthesis and antitumor activity of novel per-butyrylated glycosides of podophyllotoxin and its derivatives. Bioorg. Med. Chem., 2015, 23(7), 1437-1446.
[http://dx.doi.org/10.1016/j.bmc.2015.02.021] [PMID: 25744190]
[16]
Song, W.; Zhao, Y.; Lynch, J.C.; Kim, H.; Tang, W. Divergent de novo synthesis of all eight stereoisomers of 2,3,6-trideoxyhexopyranosides and their oligomers. Chem. Commun. (Camb.), 2015, 51(98), 17475-17478.
[http://dx.doi.org/10.1039/C5CC07787G] [PMID: 26477956]
[17]
Lu, Y.; Wang, L.; Wang, X.; Yuan, H.; Zhao, Y. Divergent de novo synthesis of 2,4,5-trideoxyhexopyranosides derivatives of podophyllotoxin as anticancer agents. Future Med. Chem., 2019, 11(23), 3015-3027.
[http://dx.doi.org/10.4155/fmc-2018-0593] [PMID: 31668097]
[18]
Wang, H.Y.L.; Qi, Z.; Wu, B.; Kang, S.W.; Rojanasakul, Y.; O’Doherty, G.A. C5′-alkyl substitution effects on Digitoxigenin α-l-glycoside cancer cytotoxicity. ACS Med. Chem. Lett., 2011, 2(4), 259-263.
[http://dx.doi.org/10.1021/ml100291n] [PMID: 21572583]
[19]
Li, M.; Li, Y.; Mrozowski, R.M.; Sandusky, Z.M.; Shan, M.; Song, X.; Wu, B.; Zhang, Q.; Lannigan, D.A.; O’Doherty, G.A. Synthesis and structure-activity relationship study of 5a-carbasugar analogues of SL0101. ACS Med. Chem. Lett., 2014, 6(1), 95-99.
[http://dx.doi.org/10.1021/ml5004525] [PMID: 25589938]
[20]
Mrozowski, R.M.; Vemula, R.; Wu, B.; Zhang, Q.; Schroeder, B.R.; Hilinski, M.K.; Clark, D.E.; Hecht, S.M.; O’Doherty, G.A.; Lannigan, D.A. Improving the affinity of SL0101 for RSK using structure-based design. ACS Med. Chem. Lett., 2012, 4(2), 175-179.
[http://dx.doi.org/10.1021/ml300298v] [PMID: 23519677]
[21]
Zhao, Y.; Ge, C.W.; Wu, Z.H.; Wang, C.N.; Fang, J.H.; Zhu, L. Synthesis and evaluation of aroylthiourea derivatives of 4-β-amino-4′-O-demethyl-4-desoxypodophyllotoxin as novel topoisomerase II inhibitors. Eur. J. Med. Chem., 2011, 46(3), 901-906.
[http://dx.doi.org/10.1016/j.ejmech.2011.01.001] [PMID: 21277655]

Rights & Permissions Print Cite
Article Metrics
11
3
© 2024 Bentham Science Publishers | Privacy Policy